Discontinuation of Intravenous Catecholamine by Oral Ivabradine in a Patient with Decompensated Heart Failure with Low Cardiac Output Syndrome.

Ryo Shibata, Jinya Takahashi, Hiromi Sato, Munehisa Bekki, Kodai Shibao, Hideya Sato, Shoichiro Nohara, Akihiro Honda, Naoki Itaya, Hidetoshi Chibana, Yoshihiro Fukumoto

The Kurume medical journal 2023 Jul 03

filter terms:

Ivabradine has been shown to improve heart failure with sinus tachycardia by reducing the heart rate without affecting left ventricular systolic function or blood pressure. Here we report a case of a catecholaminedependent patient, New York Heart Association (NYHA) class IV, LVEF of 18%, and low cardiac output, who was able to discontinue intravenous catecholamine by oral administration of ivabradine.

Citation

Ryo Shibata, Jinya Takahashi, Hiromi Sato, Munehisa Bekki, Kodai Shibao, Hideya Sato, Shoichiro Nohara, Akihiro Honda, Naoki Itaya, Hidetoshi Chibana, Yoshihiro Fukumoto. Discontinuation of Intravenous Catecholamine by Oral Ivabradine in a Patient with Decompensated Heart Failure with Low Cardiac Output Syndrome. The Kurume medical journal. 2023 Jul 03;68(2):133-140